Clinical Trial Detail

NCT ID NCT02141295
Title A Study Comparing the Efficacy and Safety of RO5520985 and FOLFOX With Bevacizumab and FOLFOX in Patients With Untreated Metastatic Colorectal Cancer (McCAVE)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors Hoffmann-La Roche
Indications

colorectal cancer

Therapies

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

RO5520985

Bevacizumab + Fluorouracil + Leucovorin

Fluorouracil + Leucovorin + RO5520985

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Age Groups: adult

No variant requirements are available.